SERAQUEST ANTI-THYROID PEROXIDASE (TPO)— 510(k) K023593

Substantially Equivalent

Quest Intl., Inc.

FDA 510(k) clearance K023593 for SERAQUEST ANTI-THYROID PEROXIDASE (TPO), Substantially Equivalent on 2003-02-06. Applicant: Quest Intl., Inc..

Clearance details

Applicant: Quest Intl., Inc.
Product code: Code JZO
Advisory panel: Immunology
Date received: 2002-10-25
Decision date: 2003-02-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: North Miami, FL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.